Showing results (1-10 of 260) with videos related to
Sort By:
Pageof 26
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 1, 1997
Sarcoidosis: recognition and treatment guidelinesO Kaye, C Ribbens, M F Kahn, et al.British Journal of Rheumatology|July 1, 1995
Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosisO Kaye, E Palazzo, M Grossin, et al.The Journal of Rheumatology|April 27, 2000
Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritisC Ribbens, B Andre, J M Jaspar, et al.European Cytokine Network|December 23, 2000
Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathiesC Ribbens, B André, O Kaye, et al.Clinical and Experimental Immunology|April 12, 2000
Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA)C Ribbens, V Bonnet, M J Kaiser, et al.Rheumatology (Oxford, England)|January 4, 2001
Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or notC Ribbens, B Andre, O Kaye, et al.British Journal of Haematology|September 6, 2000
Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantationF Baron, C Ribbens, O Kaye, et al.The Journal of Rheumatology|February 1, 1996
The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexateO Kaye, C C Beckers, P Paquet, et al.Revue Medicale De Liege|July 30, 2002
[Chronic thoracic pain]M G Malaise, O Kaye, M Radermecker, et al.Revue Medicale De Liege|August 15, 2000
[The non-recommendations in the treatment of osteoarthritis and rheumatoid arthritis, or why is evidence-based medicine so difficult (still) to apply to rheumatology?]M G MalaisePageof 26